Lucy Hocking is an analyst at RAND Europe with experience in public health, health improvement and innovation, and health services research. These research studies were commissioned by a range of clients, including the UK Department of Health and Social Care, pharmaceutical companies and the European Commission.
Hocking has been heavily involved in a study exploring innovation in the NHS and how policy can best support and enable innovation to thrive. In addition, she is currently managing a study commissioned by the Health Foundation evaluating the Q initiative. Hocking has experience with a range of qualitative and quantitative research methods, including literature review, conducting and analysing interviews with a range of key stakeholders, developing in-depth case studies, and designing and analysing surveys. She has an M.Sc. in child public health from Swansea University and a B.Sc.(Hons) in biomedical science from the University of Reading.
Lucy Hocking, Sarah Parks, Marlene Altenhofer, Salil Gunashekar, Reuse of health data by the European pharmaceutical industry: Current practice and implications for the future, European Federation of Pharmaceutical Industries and Associations (EFPIA), 2019
Daniel Gehrt, Marco Hafner, Lucy Hocking, Evangelos Gkousis, Pamina Smith, Jack Pollard, Poor indoor climate, its impact on child health, and the wider societal costs, Santa Monica, CA: RAND Corporation (RR-3256), 2019
Tom Ling, Katherine Stewart, Bryn Garrod, Lucy Hocking, Jennifer Newbould, Cloé Gendronneau, Evaluation of the Second Phase of the Q Initiative 2016–2020: Interim Report, Santa Monica, CA: RAND Corporation (RR-2324), 2018